Two new drug treatments for HER2-positive breast cancer were tested in separate studies. One study involves the drug Tucatinib, and the other involves an antibody-drug called trastuzumab deruxtecan.
from CNN.com - RSS Channel - App Health Section https://ift.tt/2PUPIkQ
No comments:
Post a Comment